PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.35%
Revenue decline while VET shows 7.01% growth. Joel Greenblatt would examine competitive position erosion.
1.37%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
-31.93%
Gross profit decline while VET shows 18.04% growth. Joel Greenblatt would examine competitive position.
-18.62%
Margin decline while VET shows 10.31% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-95.62%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-64.76%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-27.57%
Both companies reducing total costs. Martin Whitman would check industry trends.
-2.02%
Both companies reducing interest expense. Martin Whitman would check industry trends.
2.94%
D&A growth while VET reduces D&A. John Neff would investigate differences.
-30.18%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
90.34%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
-108.89%
Operating income decline while VET shows 235.39% growth. Joel Greenblatt would examine position.
-110.63%
Operating margin decline while VET shows 213.43% growth. Joel Greenblatt would examine position.
67.48%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-135.42%
Pre-tax income decline while VET shows 465.31% growth. Joel Greenblatt would examine position.
-142.34%
Pre-tax margin decline while VET shows 441.39% growth. Joel Greenblatt would examine position.
-244.19%
Tax expense reduction while VET shows 227.03% growth. Joel Greenblatt would examine advantage.
-104.03%
Net income decline while VET shows 114.44% growth. Joel Greenblatt would examine position.
-104.81%
Net margin decline while VET shows 113.49% growth. Joel Greenblatt would examine position.
-104.13%
EPS decline while VET shows 114.26% growth. Joel Greenblatt would examine position.
-104.05%
Diluted EPS decline while VET shows 114.26% growth. Joel Greenblatt would examine position.
-1.85%
Share count reduction while VET shows 0.46% change. Joel Greenblatt would examine strategy.
-0.02%
Diluted share reduction while VET shows 0.84% change. Joel Greenblatt would examine strategy.